1-Methoxyerythrabyssin II Induces Autophagy in Leukemia Cells via PI3K/Akt/mTOR Pathways
Planta Medica · 01.10.2023 · 89 (13) · 1204-1214
DOI: 10.1055/a-2114-0980 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.10.2023. Verfasst von Bo Fang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Autophagy, Pterocarpans, Leukemia, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Leukemia, despite currently being one of the most lethal cancers worldwide, still lacks a focused treatment. The purpose of the present investigation was to evaluate the pharmacological effect of 1-methoxyerythrabyssin II, a pterocarpan identified in the roots of Lespedeza bicolor, on leukemic cells and to explore its underlying mechanism using a network pharmacology strategy. 1-Methoxyerythrabyssin II showed an antiproliferative effect in a concentration-dependent manner and exhibited a higher potency in human acute leukemia T cells (Jurkat). The G1 phase arrest induced by 1-methoxyerythrabyssin II was confirmed using a cell cycle assay, and the downregulation of CDK2 and cyclin D1 was observed using an immunoblot assay. Moreover, 1-methoxyerythrabyssin II-treated cells exhibited higher expression levels of LC3B, Atg-7, and Beclin 1 in addition to an enhanced fluorescence intensity in monodansylcadaverine staining, indicating autophagy induction by 1-methoxyerythrabyssin II. Furthermore, network pharmacology and molecular docking analyses revealed that the PI3K/Akt/mTOR pathway is a potential target of 1-methoxyerythrabyssin II in leukemic cells. In vitro assays further demonstrated that 1-methoxyerythrabyssin II promoted autophagy and suppressed cell proliferation by inhibiting the PI3K/Akt/mTOR pathway in leukemic cells. This discovery will contribute to the development of novel therapeutics and prophylactics against leukemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Wenzhou Medical University, Wenzhou, China.
- Research Institute of Pharmaceutical Sciences, College of Pharmacy, Chonnam National University, Gwangju, Korea.
- Department of Veterinary Internal Medicine, College of Veterinary Medicine and BK21 FOUR Program, Chonnam National University, Gwangju, Korea.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Fang, B., Kim, S., Kim, Y., Qiu, Y., Lee, C. M., Lai, Y., Liu, Z., Wang, K., & Cho, N. (2023). 1-Methoxyerythrabyssin II Induces Autophagy in Leukemia Cells via PI3K/Akt/mTOR Pathways. Planta Medica, 89(13), 1204-1214. https://doi.org/10.1055/a-2114-0980
Vancouver
Fang B, Kim S, Kim Y, Qiu Y, Lee CM, Lai Y, et al. 1-Methoxyerythrabyssin II Induces Autophagy in Leukemia Cells via PI3K/Akt/mTOR Pathways. Planta Medica. 2023;89(13):1204-1214. doi:10.1055/a-2114-0980
BibTeX
@article{Fang2023,
author = {Fang, Bo and Kim, Soeun and Kim, Yebon and Qiu, Yinda and Lee, Chang-Min and Lai, Yinshuang and Liu, Zhiguo and Wang, Kun and Cho, Namki},
title = {1-Methoxyerythrabyssin II Induces Autophagy in Leukemia Cells via PI3K/Akt/mTOR Pathways},
journal = {Planta Medica},
year = {2023},
volume = {89},
number = {13},
pages = {1204--1214},
doi = {10.1055/a-2114-0980}
}
EUVIMED